Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 1/2024

16-11-2023 | Esophageal Cancer | Editorial

Editorial: Comparisons of COVID-19-related disturbance in diagnosis of esophagogastric cancer between the Netherlands and Japan

Authors: Katsunori Iijima, Kenta Watanabe, Yosuke Shimodaira

Published in: Journal of Gastroenterology | Issue 1/2024

Login to get access

Excerpt

The COVID-19 pandemic has had a significant impact on cancer diagnosis and treatment. Previous studies have repeatedly shown that the COVID-19 pandemic has led to a substantial decrease in the number of diagnosed gastrointestinal cancers in parallel with a decreased number of diagnostic procedures (e.g., endoscopy) [1‐3]. To accurately investigate the temporal trends in cancer incidence, a large-scale study using registry data in a defined area is important. In Japan, hospital-based cancer registries, which cover > 70% of newly diagnosed cases, are frequently employed as a reliable and rapid measure of cancer incidence [4, 5]. …
Literature
1.
Rutter MD, Brookes M, Lee TJ, et al. Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: A national endoscopy database analysis. Gut. 2021;70:537–43.CrossRefPubMed
2.
Khan A, Bilal M, Morrow V, et al. Impact of the coronavirus disease 2019 pandemic on gastrointestinal procedures and cancers in the United States: A multicenter research network study. Gastroenterology. 2021;160:2602–4.CrossRefPubMed
3.
4.
Okuyama A, Watabe M, Makoshi R, et al. Impact of the COVID-19 pandemic on the diagnosis of cancer in Japan: analysis of hospital-based cancer registries. Jpn J Clin Oncol. 2022;52:1215–24.PubMed
5.
Koizumi S, Motoyama S, Iijima K. Is the incidence of esophageal adenocarcinoma increasing in Japan? Trends from the data of a hospital-based registration system in Akita Prefecture. Japan J Gastroenterol. 2018;53:827–33.CrossRefPubMed
6.
Doeve BH, Bakx JAC, Siersema PD, et al. The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer. J Gastroenterol. 2023;58:965–77.CrossRefPubMedPubMedCentral
7.
Huang J, Lucero-Prisno DE 3rd, Zhang L, et al. Updated epidemiology of gastrointestinal cancers in East Asia. Nat Rev Gastroenterol Hepatol. 2023;20:271–87.CrossRefPubMed
8.
Morris EJA, Goldacre R, Spata E, et al. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: A population-based study. Lancet Gastroenterol Hepatol. 2021;6:199–208.CrossRefPubMedPubMedCentral
9.
Iijima K, Jin M, Miura M, et al. Disturbance of gastrointestinal cancers diagnoses by the COVID-19 pandemic in a depopulated Area of Japan: a population-based study in Akita prefecture. Tohoku J Exp Med. 2022;257:65–71.CrossRefPubMed
10.
Kodama M, Miyamori D, Kanno K, et al. The impact of early-stage COVID-19 pandemic on the diagnosis and treatment of gastric cancer: A cross-sectional study using a large-scale cancer registry in Hiroshima. Japan DEN Open. 2022;3: e180.CrossRefPubMed
11.
Kajiwara Saito M, Morishima T, et al. Diagnosis and treatment of digestive cancers during COVID-19 in Japan: a cancer registry-based study on the impact of COVID-19 on cancer care in Osaka (CanReCO). PLoS ONE. 2022;17: e0274918.CrossRefPubMedPubMedCentral
12.
Iijima K, Matsuhashi T, Shimodaira Y, et al. Impact of the COVID-19 pandemic on the performance of endoscopy in the Tohoku region of Japan. DEN Open. 2023;4: e249.CrossRefPubMedPubMedCentral
13.
Kuzuu K, Misawa N, Ashikari K, et al. Gastrointestinal cancer stage at diagnosis before and during the COVID-19 pandemic in Japan. JAMA Netw Open. 2021;4: e2126334.CrossRefPubMedPubMedCentral
14.
Ward ZJ, Walbaum M, Walbaum B, et al. Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis. Lancet Oncol. 2021;22:1427–37.CrossRefPubMedPubMedCentral
15.
Iijima K, Shimodaira Y, Watanabe K, et al. A Follow-up report on the diagnosis of gastrointestinal cancer during the COVID-19 pandemic in Akita Prefecture, Japan in 2021. Tohoku J Exp Med. 2023;259:301–6.CrossRefPubMed
16.
Koizumi S, Motoyama S, Watanabe N, et al. Chronological changes in the gastric cancer Subsite in Akita, Japan: the trends from the data of a hospital-based registration system. Tohoku J Exp Med. 2018;246:131–40.CrossRefPubMed
Metadata
Title
Editorial: Comparisons of COVID-19-related disturbance in diagnosis of esophagogastric cancer between the Netherlands and Japan
Authors
Katsunori Iijima
Kenta Watanabe
Yosuke Shimodaira
Publication date
16-11-2023
Publisher
Springer Nature Singapore
Published in
Journal of Gastroenterology / Issue 1/2024
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-023-02056-w

Other articles of this Issue 1/2024

Journal of Gastroenterology 1/2024 Go to the issue

Original Article―Liver, Pancreas, and Biliary Tract

MGAT5/TMEM163 variant is associated with prognosis in ursodeoxycholic acid-treated patients with primary biliary cholangitis

Letter to the Editor

Reply to “Ferroptosis in the colon epithelial cells as a therapeutic target for ulcerative colitis”

Letter to the Editor

The antiferroptotic effect of indigo on ulcerative colitis

Original Article—Alimentary Tract

Clinicopathologic differences of gastric neoplasms between Helicobacter pylori-infected and -naïve patients: a multicenter retrospective analysis

Original Article―Liver, Pancreas, and Biliary Tract

Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography

Original Article—Alimentary Tract

Characteristics, outcomes, and risk factors of surgery for acute lower gastrointestinal bleeding: nationwide cohort study of 10,342 hematochezia cases
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits